A specific biochemical or clinical marker utilized to support the diagnosis of hypogonadism, a condition characterized by deficient gonadal function resulting in low sex hormone production. These aids typically include measurements of total and free testosterone, along with pituitary hormones like Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). They are instrumental in distinguishing between primary (testicular/ovarian) and secondary (hypothalamic/pituitary) causes of hormonal deficiency.
Origin
This term is a clinical application of endocrinology, where ‘hypogonadism’ refers to diminished gonadal function and ‘diagnosis aid’ signifies the tools used for definitive classification. The need for precise diagnostic aids arose from the recognition that clinical symptoms alone are often non-specific. Accurate measurement is paramount for initiating appropriate hormone replacement therapy.
Mechanism
In primary hypogonadism, the gonads fail to produce adequate sex steroids, leading to a compensatory rise in LH and FSH from the pituitary, making elevated gonadotropins a key aid. Conversely, secondary hypogonadism involves a failure of the pituitary or hypothalamus, resulting in low sex steroids alongside low or inappropriately normal LH and FSH levels. The measurement of bioavailable or free sex hormones provides the most accurate reflection of tissue exposure, complementing the total hormone measurement.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.